Hovnanian Enterprises - 7.625% PRF PERPETUAL USD 25000 - Ser A EBIT

As of the most recent data (April 2026), HOVNP shows a EBIT of $790M. That compares with $1.1B in the prior-year period — down 26.5% year over year. That is below the Healthcare sector average of $23B. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, HOVNP's EBIT is now $790M (was $1.1B) — a 26.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Hovnanian Enterprises - 7.625% PRF PERPETUAL USD 25000 - Ser A is outperforming or lagging.

The Healthcare sector average EBIT is about $23B. Hovnanian Enterprises - 7.625% PRF PERPETUAL USD 25000 - Ser A is at $790M, which is lower that average. That is roughly 96.6% below the sector mean. Use the comparison chart on this page to see how HOVNP stacks up against individual peers as well.

Tracking HOVNP's ebit over time shows whether Hovnanian Enterprises - 7.625% PRF PERPETUAL USD 25000 - Ser A is scaling, shrinking, or reshaping that part of the business. The current reading is $790M That compares with $1.1B in the prior-year period — down 26.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has Hovnanian Enterprises - 7.625% PRF PERPETUAL USD 25000 - Ser A's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $790M) with ownership activity and broader fundamentals.